September 2026
The CAR-T therapies for blood cancers market generated USD 8.09 billion in 2026, with prominent CAR-T therapies for blood cancers market companies including Novartis AG, Gilead Sciences, Inc. (Kite Pharma), Bristol Myers Squibb Company (Celgene/Juno Therapeutics), Johnson & Johnson (Legend Biotech Corporation).
September 2026
The RNA editing therapies market expands with clinical progress in precision therapeutics, rare disease solutions, and gene-based medicine.
September 2026
The global oral obesity therapies market size was evaluated at USD 4.70 billion in 2026 and is predicted to hit around USD 9.34 billion by 2035, growing at a CAGR of 7.94%.
September 2026
The b-cell maturation antigen (BCMA) targeted therapies market size reached USD 6.62 billion in 2026, with leading B-Cell Maturation Antigen (BCMA) Targeted Therapies Market companies including Bristol Myers Squibb, Johnson & Johnson, GSK plc, Amgen Inc., Regeneron Pharmaceuticals, Inc.
September 2026
The global in vivo CAR-T therapy market size was evaluated at USD 861.25 million in 2026 and is predicted to hit around USD 10,841.07 million by 2035, growing at a CAGR of 32.50%.
September 2026
The U.S. radiopharmaceutical therapies market size is estimated to hit around USD 7.70 billion by 2035 increasing from USD 1.92 billion in 2025, with a CAGR of 14.9%%.
August 2026
The autologous stem cell and non-stem cell based therapies market size stood at USD 10.75 billion in 2026, with major autologous stem cell and non-stem cell based therapies market companies including Vericel Corporation, Holostem Terapie Avanzate, Anterogen Co. Ltd., BrainStorm Cell Therapeutics.
December 2025
The global lentivirus manufacturing for advanced therapies market grows with rising demand for viral vectors supporting gene therapy, CAR-T development, and advanced treatments.
August 2025
The global histoplasmosis treatment market size reached USD 2.27 billion in 2024 and is projected to surpass around USD 5.38 billion by 2034, with a solid CAGR of 9.01%.
July 2025
The non-opioid pain treatment market size was estimated at USD 48.38 billion in 2024 and is projected to hit around USD 96.25 billion by 2034 with a CAGR of 7.12%.
July 2025
The global acute migraine treatment market size was valued at USD 3.46 billion in 2024 and is expected to surge around USD 10.08 billion by 2034 with a CAGR of 11.30%.
July 2025
The prurigo nodularis treatment market size was exhibited at USD 2.22 billion in 2024 and is projected to hit around USD 3.29 billion by 2034 with a CAGR of 4.01%.
June 2025
The global glaucoma treatment market size is expected to attain around USD 8.66 billion by 2034, increasing from USD 6.51 billion in 2024, with a CAGR of 2.86%.
June 2025
The global topical drugs CDMO market size was exhibited at USD 46.62 billion in 2024 and is predicted to surpass around USD 136.39 billion by 2034, with a CAGR of 11.33%.
July 2024
The global recombinant antibodies market size was estimated at USD 12.40 billion in 2023 and is projected to surpass around USD 23.34 billion by 2033 with a CAGR of 6.53%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com